Register entry
- Registered sites
- 0
- Active NDC listings
- 8
- Live patents
- 43
- Exclusivities
- 1
- Shortage listings
- 3
- Countries
- 0
Alert
Drug shortage listings
3| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Sulconazole Nitrate SolutionDermatology | Sulconazole Nitrate, Solution, 30 mL (NDC 72143-321-30) | To Be Discontinued | - | 8 May 20268 May 2026 |
| Sulconazole Nitrate SolutionDermatology | Exelderm, Solution, 1.0% 5 mL (NDC 69489-721-05) | To Be Discontinued | - | 8 May 20268 May 2026 |
| Sulconazole Nitrate SolutionDermatology | Exelderm, Solution, 1.0% 30 mL (NDC 69489-721-30) | To Be Discontinued | - | 8 May 20268 May 2026 |
Catalogue
Drug listings by form and route
88 active NDC listings: 8 human prescription drug. By marketing category: NDA 7, ANDA 1.
| Dosage form | NDCs |
|---|---|
| aerosol, foam | 2 |
| cream | 2 |
| capsule | 1 |
| cloth | 1 |
| solution | 1 |
| tablet | 1 |
| Route | NDCs |
|---|---|
| topical | 6 |
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| journey medical corporation | 8 |
Exclusivity
Patents and exclusivities
43| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7919483 | XIMINOminocycline hydrochloride | use | Mar 2027 |
| 7541347 | XIMINOminocycline hydrochloride | use | Apr 2027 |
| 7544373 | XIMINOminocycline hydrochloride | product | Apr 2027 |
| 10052267 | QBREXZAglycopyrronium tosylate | product | Oct 2028 |
| 8618160 | QBREXZAglycopyrronium tosylate | product | Dec 2029 |
| 9744105 | QBREXZAglycopyrronium tosylate | product | Jul 2030 |
| 10086080 | AMZEEQminocycline hydrochloride | use | Oct 2030 |
| 10137200 | AMZEEQminocycline hydrochloride | use | Oct 2030 |
| 10213512 | AMZEEQ, ZILXIminocycline hydrochloride | product | Oct 2030 |
| 10265404 | AMZEEQ, ZILXIminocycline hydrochloride | product | Oct 2030 |
| 10322186 | ZILXIminocycline hydrochloride | use | Oct 2030 |
| 10517882 | AMZEEQminocycline hydrochloride | use | Oct 2030 |
| 10821187 | AMZEEQminocycline hydrochloride | use | Oct 2030 |
| 10946101 | ZILXIminocycline hydrochloride | use | Oct 2030 |
| 12138311 | ZILXIminocycline hydrochloride | use | Oct 2030 |
| 12661407 | ZILXIminocycline hydrochloride | use | Oct 2030 |
| 8865139 | AMZEEQ, ZILXIminocycline hydrochloride | product | Oct 2030 |
| 8945516 | AMZEEQ, ZILXIminocycline hydrochloride | product | Oct 2030 |
| 8992896 | AMZEEQ, ZILXIminocycline hydrochloride | product | Oct 2030 |
| 9675700 | AMZEEQ, ZILXIminocycline hydrochloride | product | Oct 2030 |
| 10004717 | QBREXZAglycopyrronium tosylate | product | Feb 2033 |
| 10543192 | QBREXZAglycopyrronium tosylate | product | Feb 2033 |
| 10548875 | QBREXZAglycopyrronium tosylate | substance, product | Feb 2033 |
| 8859610 | QBREXZAglycopyrronium tosylate | product | Feb 2033 |
| 9259414 | QBREXZAglycopyrronium tosylate | use | Feb 2033 |
| 10398641 | AMZEEQminocycline hydrochloride | use | Sept 2037 |
| 10849847 | AMZEEQminocycline hydrochloride | use | Sept 2037 |
| 10905664 | EMROSIminocycline hydrochloride | use | Jan 2039 |
| 11191740 | EMROSIminocycline hydrochloride | use | Jan 2039 |
| 11364212 | EMROSIminocycline hydrochloride | use | Jan 2039 |
| 12594252 | EMROSIminocycline hydrochloride | use | Jan 2039 |
| Product | Exclusivity | Until |
|---|---|---|
| EMROSIMINOCYCLINE HYDROCHLORIDE | NP New product | Nov 2027 |
Catalogue
Marketed products
8| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| AMZEEQ | Minocycline | aerosol, foam, topical | 69489-201NDA |
| EMROSI | Minocycline Hydrochloride Extended-Release | capsule, oral | 69489-131NDA |
| Eurax | crotamiton | cream, topical | 69489-311NDA |
| Exelderm | Sulconazole Nitrate | cream, topical | 69489-711NDA |
| Exelderm | Sulconazole Nitrate | solution, topical | 69489-721NDA |
| Qbrexza | glycopyrronium | cloth, topical | 69489-411NDA |
| TARGADOX | doxycycline hyclate | tablet, oral | 69489-111ANDA |
| ZILXI | Minocycline | aerosol, foam, topical | 69489-212NDA |
Enquiry
Common questions
- Is Journey Medical Corporation FDA approved?
- Journey Medical Corporation holds no registered establishment of its own; 8 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Journey Medical Corporation make?
- 8 products are listed under Journey Medical Corporation in the openFDA NDC Directory, most often as aerosol, foam; cream; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.